Tandem Diabetes Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Tandem Diabetes Stock Summary

Tandem Diabetes competes with DexCom, Inspire Medical, Penumbra, Insulet, and Abbott Laboratories. Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. Tandem Diabetes operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.

Tandem Diabetes Key Financial Ratios

Tandem Diabetes Key Balance Sheet Accounts

Tandem Diabetes Key Income Statement Accounts

Tandem Diabetes Key Cash Accounts

Tandem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tandem Diabetes's current stock value. Our valuation model uses many indicators to compare Tandem Diabetes value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tandem Diabetes competition to find correlations between indicators driving Tandem Diabetes's intrinsic value. More Info.Tandem Diabetes Care is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Tandem Diabetes' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tandem Diabetes by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Tandem Diabetes Care Systematic Risk

Today, most investors in Tandem Diabetes Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tandem Diabetes' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tandem Diabetes growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Tandem Diabetes help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tandem Diabetes Care. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tandem Diabetes Care based on widely used predictive technical indicators. In general, we focus on analyzing Tandem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tandem Diabetes's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.